HIGHLIGHTS: Thomas Schinecker - CEO of Roche
In Good Company with Nicolai Tangen
Balancing Drug Pricing and Innovation in Pharmaceuticals
This chapter explores the intricate dynamics of drug pricing within the pharmaceutical industry, focusing on the challenges of balancing innovation costs with societal needs. It also highlights the fulfilling role of pharmaceutical CEOs in observing the transformative effects of their products on patient health.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
